Brief: Rain Therapeutics Reports First Quarter 2021 Financial Results And Highlights Recent Progress
May 25 (Reuters) - Rain Therapeutics Inc RAIN.O :
* RAIN THERAPEUTICS REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT PROGRESS
* Q1 LOSS PER SHARE $1.93
* RAIN THERAPEUTICS - EXPECTS FULL YEAR 2021 NET CASH USED
IN
OPERATING AND INVESTING ACTIVITIES TO BE ABOUT $50.0 MILLION TO
$60.0 MILLION
* RAIN THERAPEUTICS -SEES PROJECTED YEAR END CASH BALANCE OF
ABOUT
$137.0 MILLION TO $147.0 MILLION IN CASH AND CASH EQUIVALENTS
Source text for Eikon: ID:nGNX8N2GkM
Further company coverage: RAIN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rain Oncology
See all newsBrief: Rain Enhancement Technologies Holdco - May Offer Up To $25 Million In Securities From Time To Time - SEC Filing
Brief: Rain Enhancement Technologies Holdco Inc - Q1 And Q2 2025 Financial Statements Should Not Be Relied Upon Due To Accounting Error - SEC Filing
Brief: Rain Oncology Pursuant To Proposed Deal With Pathos AI
Brief: Rain Oncology To Be Acquired By Pathos AI For $1.16 In Cash Per Share Plus Contingent Value Rights
Brief: Rain Oncology Q3 Net Income USD -7.034 Million